Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines

Mary B. Daly; Robert Pilarski; Michael Berry; Saundra S. Buys; Meagan Farmer; Susan Friedman; Judy E. Garber; Noah D. Kauff; Seema Khan; Catherine Klein; Wendy Kohlmann; Allison Kurian; Jennifer K. Litton; Lisa Madlensky; Sofia D. Merajver; Kenneth Offit; Tuya Pal; Gwen Reiser; Kristen Mahoney Shannon; Elizabeth Swisher; Shaveta Vinayak; Nicoleta C. Voian; Jeffrey N. Weitzel; Myra J. Wick; Georgia L. Wiesner; Mary Dwyer; Susan Darlow

doi:10.6004/jnccn.2017.0003

Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines

Mary B. Daly, Robert Pilarski, Michael Berry, Saundra S. Buys, Meagan Farmer, Susan Friedman, Judy E. Garber, Noah D. Kauff, Seema Khan, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer K. Litton, Lisa Madlensky, Sofia D. Merajver, Kenneth Offit, Tuya Pal, Gwen Reiser, Kristen Mahoney Shannon, Elizabeth SwisherShaveta Vinayak, Nicoleta C. Voian, Jeffrey N. Weitzel, Myra J. Wick, Georgia L. Wiesner, Mary Dwyer, Susan Darlow

Obstetrics/Gynecology

Research output: Contribution to journal › Review article › peer-review

285 Scopus citations

Abstract

The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.

Original language	English (US)
Pages (from-to)	9-20
Number of pages	12
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	15
Issue number	1
DOIs	https://doi.org/10.6004/jnccn.2017.0003
State	Published - Jan 1 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2017.0003

Cite this

Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., Kohlmann, W., Kurian, A., Litton, J. K., Madlensky, L., Merajver, S. D., Offit, K., Pal, T., Reiser, G., Shannon, K. M., ... Darlow, S. (2017). Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 15(1), 9-20. https://doi.org/10.6004/jnccn.2017.0003

Daly, MB, Pilarski, R, Berry, M, Buys, SS, Farmer, M, Friedman, S, Garber, JE, Kauff, ND, Khan, S, Klein, C, Kohlmann, W, Kurian, A, Litton, JK, Madlensky, L, Merajver, SD, Offit, K, Pal, T, Reiser, G, Shannon, KM, Swisher, E, Vinayak, S, Voian, NC, Weitzel, JN, Wick, MJ, Wiesner, GL, Dwyer, M & Darlow, S 2017, 'Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 1, pp. 9-20. https://doi.org/10.6004/jnccn.2017.0003

@article{d14311b65e6c46d49684cd063c959411,

title = "Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines",

abstract = "The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.",

author = "Daly, {Mary B.} and Robert Pilarski and Michael Berry and Buys, {Saundra S.} and Meagan Farmer and Susan Friedman and Garber, {Judy E.} and Kauff, {Noah D.} and Seema Khan and Catherine Klein and Wendy Kohlmann and Allison Kurian and Litton, {Jennifer K.} and Lisa Madlensky and Merajver, {Sofia D.} and Kenneth Offit and Tuya Pal and Gwen Reiser and Shannon, {Kristen Mahoney} and Elizabeth Swisher and Shaveta Vinayak and Voian, {Nicoleta C.} and Weitzel, {Jeffrey N.} and Wick, {Myra J.} and Wiesner, {Georgia L.} and Mary Dwyer and Susan Darlow",

note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2017",

month = jan,

day = "1",

doi = "10.6004/jnccn.2017.0003",

language = "English (US)",

volume = "15",

pages = "9--20",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "1",

}

TY - JOUR

T1 - Genetic/familial high-risk assessment

T2 - Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines

AU - Daly, Mary B.

AU - Pilarski, Robert

AU - Berry, Michael

AU - Buys, Saundra S.

AU - Farmer, Meagan

AU - Friedman, Susan

AU - Garber, Judy E.

AU - Kauff, Noah D.

AU - Khan, Seema

AU - Klein, Catherine

AU - Kohlmann, Wendy

AU - Kurian, Allison

AU - Litton, Jennifer K.

AU - Madlensky, Lisa

AU - Merajver, Sofia D.

AU - Offit, Kenneth

AU - Pal, Tuya

AU - Reiser, Gwen

AU - Shannon, Kristen Mahoney

AU - Swisher, Elizabeth

AU - Vinayak, Shaveta

AU - Voian, Nicoleta C.

AU - Weitzel, Jeffrey N.

AU - Wick, Myra J.

AU - Wiesner, Georgia L.

AU - Dwyer, Mary

AU - Darlow, Susan

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.

AB - The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/ or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=85009085880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009085880&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0003

DO - 10.6004/jnccn.2017.0003

M3 - Review article

C2 - 28040716

AN - SCOPUS:85009085880

SN - 1540-1405

VL - 15

SP - 9

EP - 20

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 1

ER -

Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017: Featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this